Continuing the Search for Knowledge

January/February

Read Article
  • Glaucoma 360 Fosters Collaboration With Industry

    Read Article
 

@GlaucomaToday

Visit @GlaucomaToday on Twitter

Articles From This Issue


 

Continuing the Search for Knowledge

COVER FOCUS

By Arsham Sheybani, MD One of the most challenging yet essential parts of practicing medicine, especially in the field of glaucoma, is staying current while not gettin…

The Education Evolution

UP FRONT

This issue marks the beginning of GT’s 15th year. It is the first recurring news publication devoted to advancing the care of glaucoma patients. In January 2003, the…

The Literature

THE LITERATURE

The Ahmed Versus Baerveldt Study: Five-Year Treatment Outcomes Christakis P, Kalenak J, Tsai JC, et al1 ABSTRACT SUMMARY This prospective, randomized, internation…

 

GlaucomaToday Polls

View All

NEWS


 

Ocular Therapeutix Announces FDA Acceptance of NDA Resubmission for Dextenza for…

Ocular Therapeutix announced that the company’s new drug application (NDA) resubmission for De…

Ocular Therapeutix Announces Additional Successful Results for Phase 3 Clinical …

Ocular Therapeutix announced additional positive secondary endpoint results from its most recent suc…

Contact Info

Bryn Mawr Communications LLC
1008 Upper Gulph Road, Suite 200
Wayne, PA 19087

Phone: 484-581-1800
Fax: 484-581-1818

Facebook Twitter

About Glaucoma Today

Glaucoma Today is mailed bimonthly (six times a year) to 11,519 glaucoma specialists, general ophthalmologists, and clinical optometrists who treat patients with glaucoma. Glaucoma Today delivers important information on recent research, surgical techniques, clinical strategies, and technology.